TABLE 2.
Treatment name | IAA (in μ g/mL) | HCN (in μ g/mL) | Inorganic phosphate (in μ g/mL) | Endoglucanase (in IU/mL) | Total cellulase (in IU/mL) | Xylanase (in nkat/mL) | Laccase (in IU/mL) |
CRRIT-1 | 31.37C | 0.03C | 318.20D | 0.67C | 0.99E | 145.35E | 2.64C |
CRRIT-2 | 42.38B | 0.27B | 412.30B | 0.70BC | 0.87F | 195.89B | 11.74A |
CRRIT-3 | 30.39C | 0.05C | 339.30C | 0.68C | 2.13B | 192.99B | 9.85B |
CRRIT-15 | 46.28A | 0.37A | 435.42A | 0.75A | 2.59A | 201.35A | 12.60A |
CRRIT-16 | 22.42D | 0.02C | 303.70DE | 0.59D | 1.09D | 152.43D | 3.35C |
CRRIT-22 | 19.19E | 0.01C | 297.49E | 0.53E | 0.97E | 149.29DE | 2.48C |
CRRIT-27 | 32.01C | 0.03C | 320.20D | 0.74AB | 1.28C | 164.40C | 2.87C |
CV (%) | 3.48 | 18.93 | 1.74 | 2.38 | 1.64 | 0.85 | 6.99 |
Tukey’s HSD at 5% | 3.1823 | 0.0601 | 17.2 | 0.0453 | 0.0665 | 4.1534 | 1.2982 |
Means with same letter are not significantly different at p ≤ 0.05.